GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Inventory-to-Revenue

Labiana Health (XMAD:LAB) Inventory-to-Revenue : 0.54 (As of Dec. 2022)


View and export this data going back to 2022. Start your Free Trial

What is Labiana Health Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Labiana Health's Average Total Inventories for the quarter that ended in Dec. 2022 was €15.66 Mil. Labiana Health's Revenue for the six months ended in Dec. 2022 was €28.79 Mil. Labiana Health's Inventory-to-Revenue for the quarter that ended in Dec. 2022 was 0.54.

Labiana Health's Inventory-to-Revenue for the quarter that ended in Dec. 2022 declined from Jun. 2022 (0.56) to Jun. 2022 (0.54)

A decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Labiana Health's Days Inventory for the six months ended in Dec. 2022 was 198.58.

Inventory Turnover measures how fast the company turns over its inventory within a year. Labiana Health's Inventory Turnover for the quarter that ended in Dec. 2022 was 0.92.


Labiana Health Inventory-to-Revenue Historical Data

The historical data trend for Labiana Health's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health Inventory-to-Revenue Chart

Labiana Health Annual Data
Trend Dec20 Dec21 Dec22
Inventory-to-Revenue
0.24 0.25 0.25

Labiana Health Semi-Annual Data
Dec20 Dec21 Jun22 Dec22
Inventory-to-Revenue - - 0.56 0.54

Competitive Comparison of Labiana Health's Inventory-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Labiana Health's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labiana Health's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Labiana Health's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Labiana Health's Inventory-to-Revenue falls into.



Labiana Health Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Labiana Health's Inventory-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Inventory-to-Revenue (A: Dec. 2022 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Dec. 2021 ) + Total Inventories (A: Dec. 2022 )) / count ) / Revenue (A: Dec. 2022 )
=( (14.919 + 13.833) / 2 ) / 57.848
=14.376 / 57.848
=0.25

Labiana Health's Inventory-to-Revenue for the quarter that ended in Dec. 2022 is calculated as

Inventory-to-Revenue (Q: Dec. 2022 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Jun. 2022 ) + Total Inventories (Q: Dec. 2022 )) / count ) / Revenue (Q: Dec. 2022 )
=( (17.481 + 13.833) / 2 ) / 28.787
=15.657 / 28.787
=0.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Labiana Health  (XMAD:LAB) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Labiana Health's Days Inventory for the six months ended in Dec. 2022 is calculated as:

Days Inventory=Average Total Inventories (Q: Dec. 2022 )/Cost of Goods Sold (Q: Dec. 2022 )*Days in Period
=15.657/14.389*365 / 2
=198.58

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Labiana Health's Inventory Turnover for the quarter that ended in Dec. 2022 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Dec. 2022 ) / Average Total Inventories (Q: Dec. 2022 )
=14.389 / 15.657
=0.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Labiana Health Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Labiana Health's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Labiana Health (XMAD:LAB) Business Description

Traded in Other Exchanges
N/A
Address
Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023
Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.